Advanced Genetics (Jun 2022)
Genetics of Ataxias in Indian Population: A Collative Insight from a Common Genetic Screening Tool
- Pooja Sharma,
- Akhilesh Kumar Sonakar,
- Nishu Tyagi,
- Varun Suroliya,
- Manish Kumar,
- Rintu Kutum,
- Vivekananda Asokchandran,
- Sakshi Ambawat,
- Uzma Shamim,
- Avni Anand,
- Ishtaq Ahmad,
- Sunil Shakya,
- Bharathram Uppili,
- Aradhana Mathur,
- Shaista Parveen,
- Shweta Jain,
- Jyotsna Singh,
- Malika Seth,
- Sana Zahra,
- Aditi Joshi,
- Divya Goel,
- Shweta Sahni,
- Asangla Kamai,
- Saruchi Wadhwa,
- Aparna Murali,
- Sheeba Saifi,
- Debashish Chowdhury,
- Sanjay Pandey,
- Kuljeet Singh Anand,
- Ranganathan Lakshmi Narasimhan,
- Sanghamitra Laskar,
- Suman Kushwaha,
- Mukesh Kumar,
- Cheruvallill Velayudhan Shaji,
- Madakasira Vasantha Padma Srivastava,
- Achal K. Srivastava,
- Mohammed Faruq,
- GOMED‐Ataxia study group
Affiliations
- Pooja Sharma
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Akhilesh Kumar Sonakar
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Nishu Tyagi
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Varun Suroliya
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Manish Kumar
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Rintu Kutum
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Vivekananda Asokchandran
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Sakshi Ambawat
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Uzma Shamim
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Avni Anand
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Ishtaq Ahmad
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Sunil Shakya
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Bharathram Uppili
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Aradhana Mathur
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Shaista Parveen
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Shweta Jain
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Jyotsna Singh
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Malika Seth
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Sana Zahra
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Aditi Joshi
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Divya Goel
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Shweta Sahni
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Asangla Kamai
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Saruchi Wadhwa
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Aparna Murali
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Sheeba Saifi
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- Debashish Chowdhury
- Department of Neurology GB Pant Hospital Delhi 110002 India
- Sanjay Pandey
- Department of Neurology GB Pant Hospital Delhi 110002 India
- Kuljeet Singh Anand
- Department of Neurology Post Graduate Institute of Medical Education and Research Dr. Ram Manohar Lohia Hospital New Delhi 110001 India
- Ranganathan Lakshmi Narasimhan
- Institute of Neurology Madras Medical College Chennai 600003 India
- Sanghamitra Laskar
- Department of Neurology Safdarjung Hospital Delhi 110029 India
- Suman Kushwaha
- Department of Neurology Institute of Human Behaviour and Allied Sciences Delhi 110095 India
- Mukesh Kumar
- Max Superspeciality Hospital Delhi 110017 India
- Cheruvallill Velayudhan Shaji
- T. D. Medical College Vandanam Alappuzha Kerala 688005 India
- Madakasira Vasantha Padma Srivastava
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Achal K. Srivastava
- Neurology Department Neuroscience Centre New Delhi 110029 India
- Mohammed Faruq
- Genomics and Molecular Medicine CSIR‐Institute of Genomics and Integrative Biology (CSIR‐IGIB) Mall Road Delhi 110007 India
- GOMED‐Ataxia study group
- DOI
- https://doi.org/10.1002/ggn2.202100078
- Journal volume & issue
-
Vol. 3,
no. 2
pp. n/a – n/a
Abstract
Abstract Cerebellar ataxias (CAs) represent a group of autosomal dominant and recessive neurodegenerative disorders affecting cerebellum with or without spinal cord. Overall, CAs have preponderance for tandem nucleotide repeat expansions as an etiological factor (10 TREs explain nearly 30–40% of ataxia cohort globally). The experience of 10 years of common genetic ataxia subtypes for ≈5600 patients’ referrals (Pan‐India) received at a single center is shared herein. Frequencies (in %, n) of SCA types and FRDA in the sample cohort are observed as follows: SCA12 (8.6%, 490); SCA2 (8.5%, 482); SCA1 (4.8%, 272); SCA3 (2%, 113); SCA7 (0.5%, 28); SCA6 (0.1%, 05); SCA17 (0.1%, 05), and FRDA (2.2%, 127). A significant amount of variability in TRE lengths at each locus is observed, we noted presence of biallelic expansion, co‐occurrence of SCA‐subtypes, and the presence of premutable normal alleles. The frequency of mutated GAA‐FRDA allele in healthy controls is 1/158 (0.63%), thus an expected FRDA prevalence of 1:100 000 persons. The data of this study are relevant not only for clinical decision making but also for guidance in direction of genetic investigations, transancestral comparison of genotypes, and lastly provide insight for policy decision for the consideration of SCAs under rare disease category.
Keywords